Bill > H592

This bill aims to prohibit the manufacturing, selling, and distributing of intravenous (IV) solution containers and IV tubing that intentionally contain DEHP (Di(2-ethylhexyl) phthalate), a toxic chemical used to make plastics more flexible. The legislation is based on extensive findings about DEHP's harmful health effects, including its classification as an endocrine-disrupting compound that can interfere with hormonal systems, potentially cause reproductive health issues, and has been linked to liver and kidney damage, respiratory problems, and possible carcinogenic effects. The bill establishes a phased implementation timeline, with IV solution containers prohibited from containing intentionally added DEHP starting January 1, 2030, and IV tubing prohibited from January 1, 2035. Manufacturers are not allowed to simply replace DEHP with another ortho-phthalate, and any unintentionally added DEHP must be below 0.1% weight per weight. The bill provides some exemptions for specific medical devices like blood collection bags and allows delayed compliance under certain conditions, such as pending FDA approvals. Additionally, the legislation introduces administrative penalties of up to $5,000 per day for violations, enforceable by the Secretary, and is designed to protect public health by reducing exposure to this potentially harmful chemical in medical devices.

Government Affairs, Health and Social Services

https://www.ncleg.gov/BillLookUp/2025/H592